epocrates logo
epocrates logo
epocrates logo
  • 0

Interaction Check

epocrates logo

Sign in to access our clinical decision support tools

Sign in Create Account

Selected Drugs Clear All

  • remove Menactra
    meningococcal polysaccharide diphtheria toxoid conjugate vaccine (MenACWY-D)
  • remove Opdualag (nivolumab/ relatlimab-rmbw)
    nivolumab/ relatlimab

multicheck MultiCheck Results - 1 Interaction

Smiley face Smiley face

Monitor/Modify Tx

Smiley face Smiley face Menactra (meningococcal polysaccharide diphtheria toxoid conjugate vaccine (MenACWY-D)) + Opdualag (nivolumab/relatlimab-rmbw) (nivolumab/ relatlimab)

Monitor/Modify Tx


meningococcal vaccine + nivolumab

if possible, vaccinate at least 2wk before starting nivolumab tx; otherwise, consider post-immunization titer check or revaccination after immunocompetence restored: combo may result in inadequate vaccine response (immunosuppressive effects)

Help
FDA Reporting Form
 
Download Epocrates from the App Store Download Epocrates from the Play Store
About Us Features Business Solutions Help & Feedback
© 2026 epocrates, Inc.    Terms of Use Privacy Policy Editorial Policy Do Not Sell or Share My Information